MEDI-1912

• Description :

  MEDI-1912 is a human monoclonal antibody (mAb) targeting NGF/bNGF. MEDI-1912 inhibits signaling through TrkA and p75 receptors. MEDI-1912 can be used in chronic pain research[1].

• UNSPSC :

  12352203

• Target :

  Neurokinin Receptor; Trk Receptor

• Related Pathways :

  GPCR/G Protein; Neuronal Signaling; Protein Tyrosine Kinase/RTK

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Inflammation/Immunology

• Smiles :

  [MEDI-1912]

• References & Citations :

  [1]Dobson CL, et al. Engineering the surface properties of a human monoclonal antibody prevents self-association and rapid clearance in vivo. Sci Rep. 2016 Dec 20;6:38644.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Inhibitory Antibodies

• Clinical Information :

  No Development Reported